Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosisMuhammad U. Rauf, Julian D. Gillmore, Adam Ioannou et al.|European Heart Journal|2023Cited by 95
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the <scp>AC‐TIVE</scp> study, an <scp>Italian nationwide survey</scp>Marco Merlo, Gianfranco Sinagra, Francesca Girardi et al.|European Journal of Heart Failure|2022Cited by 91
Secondary Prevention Medical Therapy and Outcomes in Patients With Myocardial Infarction With Non-Obstructive Coronary Artery DiseasePasquale Paolisso, Nazzareno Galiè, Ilenia Magnani et al.|Frontiers in Pharmacology|2020Cited by 87
Diagnostic Accuracy of Cardiac Computed Tomography and 18-F Fluorodeoxyglucose Positron Emission Tomography in Cardiac MassesEmanuela Concetta D’Angelo, Nazzareno Galiè, Rachele Bonfiglioli et al.|JACC. Cardiovascular imaging|2020Cited by 74
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization — the first insight from the AC-TIVE StudyMarco Merlo, Gianfranco Sinagra, Antonino Milidoni et al.|European Journal of Preventive Cardiology|2021Cited by 46